Their findings could lead to the development of a new first line targeted therapy for the treatment of triple negative breast cancer (TNBC), with the prospect of rapidly transitioning to clinical trials in humans. Breast cancer is the leading cause of cancer death in women around the world, responsible for 1,700 deaths every day. Although...